Newsroom

BAKERSFIELD, Calif.--(BUSINESS WIRE)--Kordata Dynamics exits stealth with a pre-seed funding round from MAVRK Celestia Fund, Kern Venture Group and Digital Neural Infrastructure Holdings (DNIH). A spin-out from BIOS Health, Kordata is redefining clinical trial execution, introducing a new model for AI-powered precision clinical trials at scale. Kordata’s platform will enable fast, high-quality results, even in complex therapy areas. Its unique clinical trials model also incorporates BIOS’ propr...

SAN FRANCISCO--(BUSINESS WIRE)--Hims & Hers Health, Inc. (NYSE: HIMS), the leading health and wellness platform, today announced the availability of generic semaglutide through its platform in Canada. This is Hims & Hers’ first international generic GLP-1 offering, demonstrating the company’s ability to meet the unique needs of each global market it serves while continuing its international expansion efforts. Personalized treatment plans are available starting at $149 CAD/month, making...

TORONTO--(BUSINESS WIRE)--Hims & Hers Health, Inc. (NYSE: HIMS), the leading health and wellness platform, today announced the availability of generic semaglutide through its platform for eligible customers in Canada. This makes affordable GLP-1 treatment accessible to Canadians for whom cost has long been a barrier to treatment. For eligible customers, personalised treatment plans are available starting at $149/month CAD. GLP-1 treatments have transformed obesity and metabolic health, with...

SAN FRANCISCO--(BUSINESS WIRE)--The recently announced AI-native enterprise services firm led by Anthropic, Blackstone, Hellman & Friedman, and others to help mid-size companies bring Claude into their core operations, today announced the acquisition of Fractional AI, a leading applied AI services company based in San Francisco. Fractional AI’s team and delivery capabilities will serve as the founding operational centerpiece of the new company. Fractional AI was founded in 2024 by Chris Tay...

NEW YORK--(BUSINESS WIRE)--Despite years of significant technological investments, most marketers still cannot connect ad exposure to actual purchases in real-time for measurement or optimization, according to new research released today by the Affinity Solutions Outcomes Marketing Council, a collaborative forum that includes leaders from DoubleVerify, Claritas, Lexitas and more, focused on advancing outcomes-based advertising and measurement. The study found that four in five respondents said...

BOSTON--(BUSINESS WIRE)--A record 6,000+ data leaders gathered to hear how the semantic layer is becoming the definitive cure for enterprise AI truth....

LONDON--(BUSINESS WIRE)--NTT DATA, a global leader in AI, digital business and technology services, today announced the evolution of its Global Data Centers sales and client services model as the business continues to scale to meet customers’ growing demand for agile, globally distributed data center infrastructure powering next-generation AI and cloud workloads. As organizations deploy AI and cloud platforms across multiple regions, customers increasingly require globally integrated data cente...

CENTER VALLEY, Pa.--(BUSINESS WIRE)--Shift4 (NYSE: FOUR), the global commerce technology provider powering the experience economy, today announced the launch of its third Shift4 Rescue Mission contest, partnering once again with hospitality expert and Bar Rescue star Jon Taffer. The program will award $100,000 to a community-focused restaurant or bar owner facing operational and financial challenges. Applications open today for restaurant owners nationwide seeking support to revitalize their bu...

SIOUX FALLS, S.D.--(BUSINESS WIRE)--Pathward Financial, Inc. ("Pathward Financial" or the “Company”) (Nasdaq: CASH), a U.S.-based financial holding company driven by its purpose to power financial inclusion for all, announced that the Company will pay a cash dividend of $0.05 per share for the third fiscal quarter of 2026. This dividend will be payable on July 1, 2026 to shareholders of record as of June 11, 2026. At March 31, 2026, the Company had total assets of $7.11 billion and shareholders...

MORRISVILLE, N.C.--(BUSINESS WIRE)--Arrivo Bio will be giving both an oral and poster presentation at the 2026 American Society of Clinical Psychopharmacology (ASCP) Annual Meeting, taking place May 26–29 in Miami, Florida. The presentations will highlight Forvisirvat (SP-624), Arrivo’s first-in-class oral activator of the SIRT6 enzyme, currently in a Phase 2b/3 study for major depressive disorder, with data read out expected later this year. Prior Phase 2 data demonstrated a signal of efficacy...